31 completed, 13 recruiting, 7 unknown, 5 terminated. 16 Phase 2, 9 Not applicable, 7 Phase 1, 5 Phase 3, 4 Phase 4.
Follow Albinism: new trials by email Literature Review of Albinism trials Research Report on Albinism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Haloperidol For Outpatient Symptom Management in Patients Diagnosed With Cannabinoid Hyperemesis Syndrome in the Emergrency Department Haloperidol - Cannabinoid Hyperemesis Syndrome | Early Phase 1 | Not yet recruiting | University of Illinois at Chicago | 100 | 2026-11-01 | 2026-09-01 |
| Implementation of Long-read Sequencing for the Diagnosis of Rare Diseases. Long-read sequencing - Rare Diseases, Albinism | Not yet recruiting | University Hospital, Bordeaux | 150 | 2026-02-01 | 2026-02-10 | |
| Safety and Efficacy of a Single Suprachoroidal Injection of JWK010 Gene Therapy in Subjects With Oculocutaneous Albinism Type 1 (OCA1) JWK010 gene therapy - Oculocutaneous Albinism (OCA) | Early Phase 1 | Recruiting | West China Hospital | 18 | 2025-12-22 | 2026-01-12 |
| Comparing Regorafenib Combined With Envafolimab to Physician's Choice in Patients With Metastatic Gastrointestinal Stromal Tumors Harboring KIT Exon 17 Mutations Refractory to Standard Treatment physician-selected treatment, Regorafenib + Envafolimab - GIST - Gastrointestinal Stromal Tumor, KIT Gene Mutation | Phase 2 | Recruiting | Jian Li | 100 | 2025-07-14 | 2026-04-30 |
| A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit NN3201 - Gastrointestinal Stromal Tumors, Small-cell Lung Cancer | Phase 1 | Recruiting | Novelty Nobility, Inc. | 67 | 2025-02-03 | 2025-09-23 |
| Functional Impairment in Albinism questionnaire - Albinism, Ocular | Recruiting | Fondation Ophtalmologique Adolphe de Rothschild | 50 | 2024-10-01 | 2025-02-13 | |
| National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases Inherited Ophthalmic Diseases, Hypopigmentation Disorder | Recruiting | National Eye Institute (NEI) | 1000 | 2024-07-12 | 2026-11-06 | |
| Peripheral Serotonin and Albinism Dosage of serotonin and metabolites, Blood parameters - Oculocutaneous Albinism | Recruiting | Assistance Publique - Hôpitaux de Paris | 160 | 2024-02-06 | 2025-09-12 | |
| Reproductive Options in Inherited Skin Diseases Ichthyosis, Palmoplantar Keratoses | Enrolling by invitation | Maastricht University Medical Center | 650 | 2024-01-01 | 2025-05-18 | |
| Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling Qualitative interview - Quality of Life, Ichthyosis | Recruiting | Maastricht University Medical Center | 25 | 2024-01-01 | 2025-05-18 | |
| Preoperative Imatinib Mesylate Combined With Rectal-sparing Surgery in Patients With c-KIT Gene-mutant Rectal GIST Imatinib Mesylate, Local resection - Gastrointestinal Stromal Tumor of Rectum | Phase 3 | Not yet recruiting | Fujian Medical University Union Hospital | 23 | 2023-10-01 | 2023-08-01 |
| Korean Translation and Validation of the K-HEPI in NYC Nurses Taking On Readiness Measures (N- TORM) - Disaster, Vulnerable Populations | Not applicable | Completed | Hunter College of City University of New York | 400 | 2023-07-13 | 2024-08-15 |
| Functional Tests to Resolve Unsolved Rare Diseases. Rares. Ex-vivo approach concerning 25 patients, In-vitro approach concerning 25 patients - Intellectual Disability, Rubinstein-Taybi Syndrome | Not applicable | Unknown | University Hospital, Bordeaux | 50 | 2023-01-30 | 2024-02-21 |
| Baby Detect : Genomic Newborn Screening Congenital Adrenal Hyperplasia, Familial Hyperinsulinemic Hypoglycemia 1 | Completed | Centre Hospitalier Universitaire de Liege | 6824 | 2022-09-01 | 2025-08-12 | |
| Nurses Taking On Readiness Measures - Mercer County, New Jersey Nurses Taking On Readiness Measures (N-TORM) - Disaster, Vulnerable Populations | Not applicable | Completed | Hunter College of City University of New York | 31 | 2022-03-07 | 2024-12-05 |
| Genetic Analysis and Multimodal Retinal Imaging of Asymptomatic Fovea Plana Cases in the General Population Genetic analysis, Ophthalmologic exam - Fovea Plana, Albinism | Not applicable | Completed | Fondation Ophtalmologique Adolphe de Rothschild | 20 | 2020-12-17 | 2026-01-06 |
| NGS Panel of Incomplete Forms of Ocular Albinism Blood samples - Albinism, Ocular | Completed | University Hospital, Bordeaux | 53 | 2020-11-23 | 2024-09-19 | |
| Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC data collection - Primary Immunodeficiency (PID), Congenital Bone Marrow Failure Syndromes | Recruiting | Paul Szabolcs | 50 | 2020-08-20 | 2026-01-13 | |
| Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment Masitinib, Placebo, Best Supportive Care - Indolent Systemic Mastocytosis | Phase 3 | Unknown | AB Science | 140 | 2020-07-01 | 2023-05-06 |
| 23andMe IPF Research Study No intervention - Idiopathic Pulmonary Fibrosis | Completed | 23andMe, Inc. | 690 | 2020-06-05 | 2024-12-09 |
Showing 20 of 64. Sign in to see all of them.
Piebaldism (18) · Chediak-Higashi Syndrome (16) · Granulomatous Disease, Chronic (11) · Hermanski-Pudlak Syndrome (11) · Lymphohistiocytosis, Hemophagocytic (10) · Wiskott-Aldrich Syndrome (10) · Albinism, Oculocutaneous (9) · Anemia, Sickle Cell (7) · Lymphoproliferative Disorders (7) · Mucopolysaccharidosis I (6) · Pulmonary Fibrosis (6) · Severe Combined Immunodeficiency (6) · Albinism, Ocular (5) · Anemia, Diamond-Blackfan (5)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (64) · Eye Diseases, Hereditary (64) · Genetic Diseases, Inborn (61) · Nutritional and Metabolic Diseases (59) · Metabolic Diseases (57) · Skin and Connective Tissue Diseases (56) · Metabolism, Inborn Errors (54) · Skin Diseases (54) · Skin Diseases, Genetic (53) · Amino Acid Metabolism, Inborn Errors (51) · Hypopigmentation (50) · Pigmentation Disorders (50) · Eye Diseases (47) · Hemic and Lymphatic Diseases (29)
Busulfan (4) · Cyclophosphamide (4) · Melphalan (4) · Alemtuzumab (3) · Antilymphocyte Serum (3) · Cyclosporine (3) · Imatinib Mesylate (3) · Stem Cell Transplantation (3) · fludarabine (3) · fludarabine phosphate (3) · Blood Specimen Collection (2) · Etoposide (2) · Genetic Testing (2) · Methotrexate (2) · Thiotepa (2)
National Human Genome Research Institute (NHGRI) (7) · University Hospital, Bordeaux (4) · Fondation Ophtalmologique Adolphe de Rothschild (3) · Masonic Cancer Center, University of Minnesota (3) · National Eye Institute (NEI) (3) · AB Science (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2) · Emory University (2) · Fairview University Medical Center (2) · Hunter College of City University of New York (2) · Maastricht University Medical Center (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Novartis Pharmaceuticals (2) · Paul Szabolcs (2) · 23andMe, Inc. (1)
United States (41) · France (12) · Netherlands (7) · China (3) · United Kingdom (3) · Belgium (2) · Canada (2) · Italy (2) · Russia (2) · Australia (1) · Austria (1) · Finland (1) · Germany (1) · Hong Kong (1) · Hungary (1)
Wendy J Introne, M.D. (3) · Angela Smith, MD (2) · Antoni Gostynski, MD, PhD (2) · Brian P Brooks, M.D. (2) · K. Scott Baker (2) · Paul Szabolcs, MD (2) · Albert Wolkerstorfer, MD, PhD (1) · Cem Akin, M.D., Ph.D. (1) · Cristina Bulai Livideanu, MD, MSc (1) · Curt Scharfe, MD, PhD (1) · David R Adams, M.D. (1) · Fang Lu (1)
PMID 29445374, PMID 30369044, PMID 20966063, PMID 26095669, PMID 28069279, PMID 30674731, PMID 31315600, PMID 31599480, PMID 32634238, PMID 32750127, PMID 35142618, PMID 36048877, PMID 38922562, PMID 40546025
2016 (1), U54HL127672 (1)